Recent Company News

• 11:48 AM ET Aug 20, 2025
  

  Regeneron higher following updates on Eylea HD submissions

• 04:07 PM ET Aug 19, 2025
  

  Madrigal announces European Commission approval of Rezdiffra in MASH with moderate to advanced liver fibrosis ($379.55, 0.00)

• 09:03 AM ET Aug 19, 2025
  

  CDC to convene two-day public meeting on HCV diagnosis

• 08:11 AM ET Aug 18, 2025
  

  Adaptive Biotechnologies discloses termination of collaboration agreement with Genentech - 8-K ($13.04, 0.00)

• 06:05 AM ET Aug 18, 2025
  

  Natera announces positive topline results from Phase III IMvigor011 clinical trial ($163.02, 0.00)

• 06:09 AM ET Aug 11, 2025
  

  StreetAccount Macro Headlines:

• 06:53 AM ET Aug 11, 2025
  

  Healthcare, telecom and insurance best performers; industrials, utilities the big laggards:

• 01:20 AM ET Aug 08, 2025
  

  Morgan Stanley downgrades RHHBY, ROG.SW

• 02:27 AM ET Aug 07, 2025
  

  Roche Holding downgraded to hold from buy at Vontobel (CHF 248.60, 0.00)